4-(Cyclopropylamino)-2-[3-(1,3-oxazol-5-yl)anilino]pyrimidine-5-carboxamide | 1198304-46-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 4-(Cyclopropylamino)-2-[3-(1,3-oxazol-5-yl)anilino]pyrimidine-5-carboxamide
• CAS: 1198304-46-9
• 化学式: C₁₇H₁₆N₆O₂
• 分子量: 336.353
• InChiKey: ZVWJCHJAIQAXOX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  25
• 可旋转键数：
  6
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  119
• 氢给体数：
  3
• 氢受体数：
  7

文献信息

• Inhibitors of protein kinases
  申请人：Bauer Shawn M.

  公开号：US20090318407A1

  公开（公告）日：2009-12-24

  The present invention is directed to compounds of formula I-II and pharmaceutically acceptable tautomers, salts, or stereoisomers thereof which are inhibitors of syk and/or JAK kinase. The present invention is also directed to intermediates used in making such compounds, the preparation of such a compound, pharmaceutical compositions containing such a compound, methods of inhibition syk and/or JAK kinase activity, methods of inhibition the platelet aggregation, and methods to prevent or treat a number of conditions mediated at least in part by syk and/or JAK kinase activity, such as undesired thrombosis and Non Hodgkin's Lymphoma.

  本发明涉及式I-II化合物及其药学上可接受的互变异构体、盐或立体异构体，其是SYK和/或JAK激酶的抑制剂。本发明还涉及用于制备这种化合物的中间体，该化合物的制备，含有该化合物的制药组合物，抑制SYK和/或JAK激酶活性的方法，抑制血小板聚集的方法，以及预防或治疗由SYK和/或JAK激酶活性至少部分介导的多种疾病，如不良血栓和非霍奇金淋巴瘤的方法。
• INHIBITORS OF PROTEIN KINASES
  申请人：Portola Pharmaceuticals, INC.

  公开号：US20140031361A1

  公开（公告）日：2014-01-30

  The present invention is directed to compounds of formula I-II and pharmaceutically acceptable tautomers, salts, or stereoisomers thereof which are inhibitors of syk and/or JAK kinase. The present invention is also directed to intermediates used in making such compounds, the preparation of such a compound, pharmaceutical compositions containing such a compound, methods of inhibition syk and/or JAK kinase activity, methods of inhibition the platelet aggregation, and methods to prevent or treat a number of conditions mediated at least in part by syk and/or JAK kinase activity, such as undesired thrombosis and Non Hodgkin's Lymphoma.

  本发明涉及式I-II化合物及其药学上可接受的互变异构体、盐或立体异构体，其是syk和/或JAK激酶的抑制剂。本发明还涉及用于制备这种化合物的中间体，制备这种化合物的方法，含有这种化合物的药物组合物，抑制syk和/或JAK激酶活性的方法，抑制血小板聚集的方法，以及预防或治疗至少部分由syk和/或JAK激酶活性介导的多种疾病的方法，例如不良血栓形成和非何杰金淋巴瘤。
• US8138339B2
  申请人：——

  公开号：US8138339B2

  公开（公告）日：2012-03-20
• US8937070B2
  申请人：——

  公开号：US8937070B2

  公开（公告）日：2015-01-20